Conditions: Gastric Neoplasms; Gastroesophageal Junction Adenocarcinoma
Interventions: Biological: Pembrolizumab; Drug: Paclitaxel
Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting - verified January 2017
How Phenotype Guides Management of the Most Common Malignant Salivary Neoplasms of the Larynx? - Abstract Salivary gland carcinomas of the larynx are uncommon. Adenoid cystic carcinoma is the most prevalent type of salivary gland carcinoma in this reg...